Excerpts

A significantly lower coronal deviation on the abutment level was observed for the PS52 and A impressions ( p < 0.001) and T3 just missing significance ( p = 0.050). 3.2.

However, compared to immediately after cooling, the FTRS total was borderline significant 25′ after cooling ( p = 0.05) and significantly greater post-50′ cooling ( p < 0.0001).

End-effector robots (n = 6) showed significant improvement (SMD = 0.30, 95% CI: 0.03–0.58, p = 0.030, I 2 = 0%), while exoskeletons showed a trend (SMD = 0.72, 95% CI: −0.01 to 1.45, p = 0.050, I 2 = 78%) ( Figure 3 B). 3.4.3.

Finally, a non-significant trend for zinc deficiency was found in PPI users (81.2 ± 13.9 versus 87.0 ± 12.7, p = 0.08) and also a borderline significant trend for lower sodium levels in PPI users (139.8 ± 3.8 versus 141.8 ± 4.6, p = 0.05).

Changes in Renal Profile Following SGLT2 Inhibitor Treatment in Diabetic Patients Figure 3 presents the assessment of the renal profile, showing an interesting trend towards a decrease in eGFR, only for male patients, following the initiation of SGLT2 inhibitor treatment (49 Q1–Q3: 28–73 vs. 43 Q1–Q3: 27.5–69; p -value < 0.05).

The results showed that in patients with necrotising soft tissue infection, an increase in L-NMMA entailed an increase in arginine ( p < 0.0001), homoarginine ( p = 0.027), and ADMA ( p < 0.0001); there was also a positive correlation between arginine and homoarginine ( p = 0.029) and arginine and ADMA ( p = 0.007); the correlation between homoarginine and IL-10 was at the limit of significance ( p = 0.050); the other correlations did not reach statistical significance ( Figure 4 A).

However, TTM at 32–34°C showed a trend towards better neurological outcomes when compared to “uncontrolled” normothermia (RR: 1.42 (95%CI 1.00, 2.03), p = 0.05).

A near-significant difference in time since the cardiovascular event (39.41 vs. 34.94 days, p = 0.05) was observed between DM and non-DM patients ( Table 1 ).

When only adipokines are included in the model, solely the association between adiponectin levels and risk of RA was close to significance (OR: 1.05, per 1000 ng/mL; 95% CI: 1.00–1.10, p = 0.05; Table 3 (A Model 1)).

When comparing the different clinical groups of the PH patients, only LVEF showed a trend of difference, mainly driven by the decreased values in the PH group 2 and group 2/3 ( p = 0.050). 3.2.

Regardless of the definition, the prevalence of LUTS showed an increasing trend with age for both men and women ( p < 0.05; Figure 1 ).

There was a marginally significant interaction between TMAO and BCAA ( p = 0.05), which is graphically depicted in Figure 2 .

There were significant correlations between BMI reduction and increase of SDNN-I (r = 0.281, p = 0.04; Figure 2 ) and also nearly significant correlations for increase of SDNN (r = 0.267, p = 0.05) and SDANN (r = 0.256, p = 0.07).

However, this was of borderline significance p = 0.05.

Within macula-on patients, there was a borderline significant increase over time (0.011 [0.00005; 0.022], p = 0.050).

Pre-op LVEF was associated with the risk of post-op respiratory failure (OR 0.97, 95% CI 0.96–0.99, p = 0.01), whereas pre-op pulmonary hypertension showed borderline significance as a predictive factor (OR 2.01, 95% CI 0.98–4.09, p = 0.05). - Wound dehiscence and delirium Our logistic regression analysis revealed obesity was not a risk factor for either wound dehiscence or delirium (OR: 1.71, 95% CI: [0.885–3.336], p = 0.11; OR: 1.03, 95% CI: [0.34–3.13], p = 0.95, respectively).

Analysis of our data did not reveal a statistically significant association between physical or mental multimorbidity and rates of irreversible organ damage (SDI ≥ 1), although the total number of physical comorbidities showed a trend for correlation with the SDI (Spearman’s rho = 0.126, p = 0.050).

In analogous analysis of two polymorphisms, -31 and -RN, the difference of distribution showed a trend resulting from 37% of patients with MI before 60 in the group -31CT/-RN11 and 72% in the group -31CT/-RN12 ( p = 0.05 in Fisher’s exact test).

Following the SGLT2 inhibitor treatment, there was an increasing trend in ALP levels for both female and male patients (female: 96 Q1–Q3: 74.25–123.75 vs. 100 Q1–Q3: 78–126; male: 91 Q1–Q3: 69–127 vs. 94 Q1–Q3: 70–130) ( p -value < 0.05).

While the EBL, preoperative Hb level, and changes between pre- and postoperative Hb levels were nominally significant ( p < 0.05), their P values were higher than the adjusted P values (0.003); therefore, the results were not significant.

These included female sex (OR 1.31, 95% CI 1.07–1.60, p = 0.001), previous CABG (OR 1.6, 95% CI 1.18–2.17, p = 0.03) and atrial fibrillation (OR 1.84, 95% CI 1.47–2.29, p < 0.001) Patients with renal dysfunction were also at increased risk of readmission with a strong trend towards significance (OR 1.40, 95% CI 1.00 to 1.96, p = 0.05).

Variables demonstrating a tendency toward significance in univariate testing ( p < 0.05) were included in a multivariate analysis.

24,534 mm 2 , p = 0.015) and nearly reached significance at the age of 10 years (9572 vs. 12,294 mm 2 , p = 0.05).

When including all randomised participants in this mediation model (mITT), the overall indirect effect was weaker, just missing significance at p ≤ 0.05; ab coefficient = 0.69 [95% CI −0.01 to 2.36], SES = 0.03. 4.

However, confirming the association between GOT levels and muscular metabolism and function, GOT levels were also found to be significantly associated with gait speed and almost significantly with grip strength ( p = 0.05).